Biotechnology Stocks I Performance Guide: Summit Therapeutics Inc. (SMMT)
SMMT has no dividends.
Table and Chart of SMMT Performance
See what a $1,000 investment in SMMT is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| SMMT Returns | |
|---|---|
| Start Date | Apr-30-2015 |
| Start Price | $10.44 |
| End Date | May-10-2024 |
| End Price | $4.65 |
| # Prices | 110 |
| Min Date | Nov-30-2022 |
| Min Price | $0.80 |
| Max Date | Jul-31-2017 |
| Max Price | $13.98 |
| Total Return | -55.46% |
| Annualized Return | -8.44% |
| Current Value of $1,000 Purchase | $445 |
| Number Returns | 5,995 |
| Average Return | -9.34% |
| Number Profitable Returns | 1,917 |
| Percent Profitable Returns | 31.98% |
| Number Unprofitable Returns | 4,078 |
| Percent Unprofitable Returns | 68.02% |
| Profitable to Unprofitable Returns Ratio | 0.47 |
| SMMT Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $3,355,465,000 |
| Beta | -1.134 | Price to Sales | 753.90 |
| Earnings per Share | $0.3800 |
| PE Ratio | 12.58 |
| PE to Growth Ratio | 0 |
| Price to Book | 33.1 |
| PRICE DATA | |
| 52 Week High | $5.39 |
| 52 Week Low | $1.5 |
| Analyst Target Price | $6.5 |
| 50-Day Moving Average | $4.08 |
| 200-Day Moving Average | $2.866 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -130.6% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
SMMT Compare Returns with S&P 500
SMMT Trendline Chart
SMMT Moving Average Chart
SMMT Stock Return Map - See Patterns of Gains and Losses
SMMT Stock Returns/Purchase Dates